25 Oct 2009 ... Tysabri sales lift Elan revenues. Athlone-based pharmaceutical group Elan has
today reported net income of $52.3 million for its fiscal ...

www.topix.com/who/elan

Glowing Tysabri Sales Data Fails To Lift Biogen Idec. ... Tysabri is co-marketed
by Biogen Idec and Elan Pharmaceuticals Inc., a subsidiary of Elan Corp plc ...

www.nasdaq.com/aspx/company-news-story.aspx?storyid=201001130029rttraderu

21 Oct 2009 ... Revenue from the biopharmaceuticals business was up 10%, but revenue from Elan
Drug ... Elan results Tysabri sales grow 19%. Elan results ...

www.rte.ie/business/2009/1021/elan.html

16 Apr 2009 ... Biogen Idec Tysabri Sales Fall Shy of Street Expectations ... Even though Biogen
and its marketing partner, Elan, have started playing up ...

www.xconomy.com/boston/2009/04/16/biogen-idec-tysabri-sales-fall-shy-of-s

25 Mar 2009 ... Biogen Idec, Elan's partner in the development and sale of Tysabri, ... In 2008,
Tysabri generated $813 million (€604 million) in revenue. ...

www.irishtimes.com/newspaper/finance/2009/0325/1224243369346.html

Glowing Tysabri Sales Data Fails To Lift Biogen Idec ... Elan Corporation, plc.
Weltbekannter Yogi Baron Baptiste enthüllt neues Programm, das Menschen mit ...

www.silobreaker.com/1-billion-sales-for-tysabri-5_2263163182606450798

31 Oct 2008 ... MS drug sales lift Elan Elan has seen revenue for the third quarter ... year has
contracted a life threatening illness after taking Tysabri, ...

prospect.rsc.org/blogs/cw/?p=1241

In the United States , Elan purchases Tysabri from Biogen Idec and is
responsible for distribution. Consequently, Elan records as revenue the net
sales of ...

newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-pressroomarticle&ID=134435

Biogen Idec suspends Tysabri sales after patient death. ... Biogen Idec and Elan
Announce TYSABRI(R) Safety Evaluation Update ...

www.encyclopedia.com/doc/1G1-167763147.html

19 Dec 2008 ... It's been a tough year for Elan shareholders. Company CEO Kelly Martin says he's
working on a turnaround.

blogs.wsj.com/health/2008/12/19/elan-ceo-defends-tysabri-sales-citing-goo